Yang et al. found 38% of bladder cancer patients have a PPARγ gene amplification, which indicates the unbalance between TR4 and PPARγ plays an important role in both PCa and bladder cancer (21). This evidence concerns the gene PPARG and urinary bladder carcinoma.